Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-7.56M.
ENTERPRISE VALUE (EV)
$-7.56M
Revelation Biosciences, Inc.
Market Cap
$3.12M
Enterprise Value (EV)
$-7.56M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Revelation Biosciences, Inc. (REVB) | $3.12M | $-7.56M |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.07M | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.17M | $3.18M |
| IceCure Medical Ltd (ICCM)vs › | $3.20M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $2.99M | $21.25M |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.25M | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.29M | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.34M | $955411.00 |
| Moolec Science S.A. (MLEC)vs › | $3.37M | N/A |
| Eocene Ltd. (EOCN)vs › | $3.46M | N/A |
Market Cap
$3.12M
Total Debt
$23013.00
Cash
$10.70M
Enterprise Value
$-7.56M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
